BWAY - Brainsway Ltd

BWAY - Brainsway Ltd

https://www.brainsway.com

Momentum: Bearish

Recent News

Powered by Alpha Vantage

BrainsWay to Present at the H.C. Wainwright Annual Global Investment Conference

GlobeNewswire • 3 years ago • score: 0.18

BURLINGTON, Mass. and JERUSALEM, Aug. 31, 2022 ( GLOBE NEWSWIRE ) -- BrainsWay Ltd. ( NASDAQ & TASE: BWAY ) ( "BrainsWay" or the "Company" ) , a global leader in advanced and non-invasive treatment for brain disorders, today announced that Christopher von Jako, Ph.D., President and Chief ...

BrainsWay's Stimulation Device Scores FDA Approval For Depression Settings

Benzinga • 3 years ago • score: -0.41

The FDA has granted 510 ( k ) clearance to BrainsWay Ltd's BWAY Deep Transcranial Magnetic Stimulation ( TMS ) H7 Coil for its use in treating adults suffering from major depressive disorder and depression, including those with comorbid anxiety symptoms commonly known as anxious depression.

What's Going On With BrainsWay Stock Today

Benzinga • 3 years ago • score: -0.38

BrainsWay Ltd BWAY shares are trading higher Monday after the company announced it received FDA clearance for its Deep TMS H7 Coil for use in treating adults suffering from major depressive disorder and depression.

Despite Competition This Analyst Finds BrainsWay Attractive

Benzinga • 3 years, 1 month ago • score: 0.11

Yesterday BrainsWay Ltd BWAY reported Q2 sales of $8.0 million, up 14% Y/Y, missing the consensus of $8.47 million, amid a slowdown in capital equipment orders, particularly in the U.S.

BrainsWay Reports Second Quarter 2022 Financial Results and Operational Highlights

GlobeNewswire • 3 years, 1 month ago • score: 0.10

Revenue Growth of 14% Year-over-Year in ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

Brainsway Ltd., a commercial-stage medical device company, focuses on the development and sale of non-invasive neuromodulation products in Israel and internationally. The company is headquartered in Jerusalem, Israel.

52W High

$16.06

52W Low

$7.09

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.32

Valuation

Rich

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

56.61

Forward P/E (<15 better)

58.82

EV/EBITDA (<8 favorable)

26.93

EV/Revenue (<3 favorable)

4.85

P/S (TTM) (<3 favorable)

6.50

P/B (<3 favorable)

4.40

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

6.40%

Institutions (25–75% balanced)

31.06%

Shares Outstanding

18,901,800

Float

25,930,200

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

46,084,000

Gross Profit (TTM)

34,341,000

EPS (TTM)

0.28

Profit Margin (>10% good)

0.12%

Operating Margin (TTM) (higher better)

0.05%

ROE (TTM) (>15% strong)

0.10%

EPS YoY (Quarterly) (>10% good)

1.50

Revenue YoY (Quarterly) (>8% good)

0.26

Momentum

Bearish momentum

Value

0.8703

Previous

0.9247

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025